title: Soluble interleukin-2 receptor is involved during systemic mycosis.
authors.forename: B F
authors.initials: BF
authors.lastname: Chumpitazi
authors.forename: B
authors.initials: B
authors.lastname: Lebeau
authors.forename: C
authors.initials: C
authors.lastname: Legeais
authors.forename: F
authors.initials: F
authors.lastname: Peyron
authors.forename: S
authors.initials: S
authors.lastname: Picot
authors.forename: P
authors.initials: P
authors.lastname: Ambroise-Thomas
authors.forename: R
authors.initials: R
authors.lastname: Grillot
mesh_terms: D000328:Adult; D000368:Aged; D001228:Aspergillosis / Q000209:etiology / Q000276:immunology; D002177:Candidiasis / Q000209:etiology / Q000276:immunology; D003453:Cryptococcosis / Q000209:etiology / Q000276:immunology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000209:etiology / Q000276:immunology*; D015375:Receptors, Interleukin-2 / Q000032:analysis*; D012189:Retrospective Studies; D012995:Solubility
chemical_list: D015375:Receptors, Interleukin-2